Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Abstract Background HCV treatment uptake has drastically increased in HIV-HCV coinfected patients in France since direct-acting antiviral (DAA) treatment approval, resulting in HCV cure in 63% of all HIV-HCV patients by the end of 2015. We investigated the impact of scaling-up DAA on HCV prevalence...

Full description

Bibliographic Details
Main Authors: Victor Virlogeux, Fabien Zoulim, Pascal Pugliese, Isabelle Poizot-Martin, Marc-Antoine Valantin, Lise Cuzin, Jacques Reynes, Eric Billaud, Thomas Huleux, Firouze Bani-Sadr, David Rey, Anne Frésard, Christine Jacomet, Claudine Duvivier, Antoine Cheret, Laurent Hustache-Mathieu, Bruno Hoen, André Cabié, Laurent Cotte, the Dat’AIDS Study Group
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Medicine
Subjects:
HIV
HCV
Coinfection
Treatment uptake
Mathematical modeling
Compartmental model
Online Access:http://link.springer.com/article/10.1186/s12916-017-0979-1

Internet

http://link.springer.com/article/10.1186/s12916-017-0979-1

Similar Items